Evidence map›Paper›PMID 22536383›Full record

ArticlePloS one2012

Mutagenesis and functional studies with succinate dehydrogenase inhibitors in the wheat pathogen Mycosphaerella graminicola.

Gabriel Scalliet, Judith Bowler, Torsten Luksch, Lucy Kirchhofer-Allan, Diana Steinhauer, Keith Ward, Michael Niklaus, Andreas Verras, Michael Csukai, Antoine Daina and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
20.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 191 citations in OpenAlex.

  1. Article
  2. Assessing the predictability of fungicide resistance evolution through in vitro selection.Journal of plant diseases and protection : scientific journal of the German Phytomedical Society (DPG) · 2024
    Article
  3. Mechanism of Pydiflumetofen Resistance inJournal of fungi (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Resistance to the SDHI Fungicides Boscalid and Fluopyram inJournal of fungi (Basel, Switzerland) · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Wheat pathogenRSC chemical biology · 2020
    Article
  15. Article
  16. Fungicide Sensitivity Shifting ofFrontiers in plant science · 2020
    Article
  17. Article
  18. Article
  19. The evolutionary origins of pesticide resistance.Biological reviews of the Cambridge Philosophical Society · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Gabriel ScallietSyngenta Crop Protection Münchwilen AG, Stein, Switzerland. gabriel.scalliet@syngenta.com
Judith Bowler
Torsten Luksch
Lucy Kirchhofer-Allan
Diana Steinhauer
Keith Ward
Michael Niklaus
Andreas Verras
Michael Csukai
Antoine Daina
Raymonde Fonné-Pfister
Syngenta (Switzerland) · CHSyngenta (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A range of novel carboxamide fungicides, inhibitors of the succinate dehydrogenase enzyme (SDH, EC 1.3.5.1) is currently being introduced to the crop protection market. The aim of this study was to explore the impact of structurally distinct carboxamides on target site resistance development and to assess possible impact on fitness. We used a UV mutagenesis approach in Mycosphaerella graminicola, a key pathogen of wheat to compare the nature, frequencies and impact of target mutations towards five subclasses of carboxamides. From this screen we identified 27 amino acid substitutions occurring at 18 different positions on the 3 subunits constituting the ubiquinone binding (Qp) site of the enzyme. The nature of substitutions and cross resistance profiles indicated significant differences in the binding interaction to the enzyme across the different inhibitors. Pharmacophore elucidation followed by docking studies in a tridimensional SDH model allowed us to propose rational hypotheses explaining some of the differential behaviors for the first time. Interestingly all the characterized substitutions had a negative impact on enzyme efficiency, however very low levels of enzyme activity appeared to be sufficient for cell survival. In order to explore the impact of mutations on pathogen fitness in vivo and in planta, homologous recombinants were generated for a selection of mutation types. In vivo, in contrast to previous studies performed in yeast and other organisms, SDH mutations did not result in a major increase of reactive oxygen species levels and did not display any significant fitness penalty. However, a number of Qp site mutations affecting enzyme efficiency were shown to have a biological impact in planta.Using the combined approaches described here, we have significantly improved our understanding of possible resistance mechanisms to carboxamides and performed preliminary fitness penalty assessment in an economically important plant pathogen years ahead of possible resistance development in the field.

Indexed as

MutagenesisAmino Acid SequenceAscomycotaBenzamidesBinding SitesBiphenyl CompoundsCarboxinComputer SimulationConserved SequenceDrug Resistance, FungalFungal ProteinsFungicides, IndustrialInhibitory Concentration 50Models, MolecularMolecular Sequence DataNiacinamide2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide3-(difluoromethyl)-1-methyl-N-(1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl)pyrazole-4-carboxamideBenzamidesBiphenyl CompoundsCarboxinFungal ProteinsFungicides, IndustrialN-(2-(3-chloro-5-(trifluoromethyl)-2-pyridyl)ethyl)-alpha,alpha,alpha-trifluoro-o-toluamideNiacinamideNorbornanesPyrazolesPyridinesSuccinate Dehydrogenase

Identifiers

PMID22536383
PMCPMC3334918
OpenAlexW2020901288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.